STAAR Surgical (STAA) said it received no takeover offers during its go-shop period that expired on Saturday. STAAR (STAA) said 21 parties were contacted during its go-shop period, through none of the ...

Dec 9 (Reuters) - Swiss eyecare giant Alcon (ALCC.S), opens new tab has made a new offer for Staar Surgical (STAA.O), opens new tab worth $1.6 billion, it said on Tuesday, as it seeks to clinch a deal ...

STAAR Surgical (STAA) rose 4.4% in after-hours trading after proxy adviser ISS recommended that shareholders vote to approve Alcon's revised $30.75 a share offer. The ISS news comes after rival proxy ...

LAKE FOREST, Calif., December 11, 2025--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ICL™) for ...

In August, the eye care company Alcon agreed to acquire STAAR Surgical, the manufacturer of the implantable collamer lens, for a total equity value of approximately $1.5 billion. On Tuesday, Alcon ...

Geneva, Switzerland-based eye care company Alcon has upped its bid to purchase competitor Staar Surgical, increasing its offer from $1.5 to $1.6 billion amid ongoing opposition to the deal. The new ...

LAKE FOREST, Calif., December 15, 2025--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an amended merger agreement for the acquisition of STAAR ...

Investing.com -- The protracted, $1.6 billion dollar saga over STAAR Surgical Company (NASDAQ:STAA) is entering its final, chaotic phase with the acquisition by Alcon AG (NYSE:ALC) now hinged on a ...

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us” or “our”) today reacted to the proxy statement supplement filed by STAAR Surgical Company ...

・Alcon raised its offer to $30.75 per share after no rival bids emerged. ・Broadwood said the process was flawed and STAAR is worth more than the new price. ・The revised bid represents a 74% premium to ...